Skip to content
10-Q

Quarterly Report

Checkmate Pharmaceuticals, Inc.

0001193125-21-327303

← back to feed
Filed
Nov 12, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 11, 2021 21.63M sh
Stock Repurchased Q3 2021 · Sep 30, 2021 $3.55M
Stock Repurchased Q3 2021 · Sep 30, 2020 $2.49M
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$43.72M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$27.42M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $53.49M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $43.06M
Stockholders Equity Q3 2021 · Sep 30, 2021 $81.53M
Stockholders Equity Q3 2021 · Jun 30, 2021 $94.98M
Stockholders Equity Q3 2021 · Mar 31, 2021 $112.4M
Stockholders Equity Q3 2021 · Dec 31, 2020 $125.2M
Stockholders Equity Q3 2021 · Sep 30, 2020 $135.21M
Stockholders Equity Q3 2021 · Jun 30, 2020 −$117.8M
Stockholders Equity Q3 2021 · Mar 31, 2020 −$106.93M
Stockholders Equity Q3 2021 · Dec 31, 2019 −$97.44M
Current Liabilities Q3 2021 · Sep 30, 2021 $7.81M
Current Liabilities Q3 2021 · Dec 31, 2020 $7.88M
Total Liabilities Q3 2021 · Sep 30, 2021 $7.81M
Total Liabilities Q3 2021 · Dec 31, 2020 $7.88M
Current Assets Q3 2021 · Sep 30, 2021 $88.67M
Current Assets Q3 2021 · Dec 31, 2020 $102.1M
Total Assets Q3 2021 · Sep 30, 2021 $89.34M
Total Assets Q3 2021 · Dec 31, 2020 $133.07M
Sga Expense Q3 2021 · Sep 30, 2021 $3.61M
Sga Expense Q3 2021 · Sep 30, 2021 $11.5M
Sga Expense Q3 2021 · Sep 30, 2020 $3.16M
Sga Expense Q3 2021 · Sep 30, 2020 $6.47M
Rd Expense Q3 2021 · Sep 30, 2021 $11.38M
Rd Expense Q3 2021 · Sep 30, 2021 $36.62M
Rd Expense Q3 2021 · Sep 30, 2020 $6.67M
Rd Expense Q3 2021 · Sep 30, 2020 $19.46M
Net Income Q3 2021 · Sep 30, 2021 −$14.97M
Net Income Q3 2021 · Sep 30, 2021 −$48.06M
Net Income Q3 2021 · Jun 30, 2021 −$18.97M
Net Income Q3 2021 · Mar 31, 2021 −$14.13M
Net Income Q3 2021 · Sep 30, 2020 −$9.83M
Net Income Q3 2021 · Sep 30, 2020 −$25.98M
Net Income Q3 2021 · Jun 30, 2020 −$8.35M
Net Income Q3 2021 · Mar 31, 2020 −$7.8M
Operating Income Q3 2021 · Sep 30, 2021 −$14.98M
Operating Income Q3 2021 · Sep 30, 2021 −$48.12M
Operating Income Q3 2021 · Sep 30, 2020 −$9.83M
Operating Income Q3 2021 · Sep 30, 2020 −$25.93M